Back
ProShares UltraShort 20+ Year Treasury Vs. Janux Therapeutics Industry Stock Comparison
Sell
43
TBT
ProShares UltraShort 20+ Year Treasury
Last Price:
32.08
Seasonality Move:
0.65%
Sell
34
JANX
Janux Therapeutics
Last Price:
66.94
Seasonality Move:
133.13%
Sell
43
ProShares UltraShort 20+ Year Treasury (TBT)
is a Sell
Is ProShares UltraShort 20+ Year Treasury a Buy, Sell or Hold?
- The current ProShares UltraShort 20+ Year Treasury [TBT] share price is $32.76. The Score for TBT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- TBT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy, Sell or Hold?
- The current Janux Therapeutics [JANX] share price is $59.86. The Score for JANX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- JANX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TBT Stock Price Chart
What is ProShares UltraShort 20+ Year Treasury's stock price today?
-
The ProShares UltraShort 20+ Year Treasury share price today is $32.76
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TBT is experiencing buying pressure, which is a positive indicator for future bullish movement.
JANX Stock Price Chart
What is Janux Therapeutics's stock price today?
-
The Janux Therapeutics share price today is $59.86
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.
TBT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 44.13 | Sell |
| Chaikin Money Flow: | 610874 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.08 - 34.92) | Sell |
| Bollinger Bands (100): | (29.86 - 33.84) | Buy |
JANX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.63 | Sell |
| Relative Strength Index (14 RSI): | 63.62 | Buy |
| Chaikin Money Flow: | -6955717 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.07 - 55.53) | Buy |
| Bollinger Bands (100): | (41.63 - 51.75) | Buy |
TBT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.36 | Sell |
| 20-day SMA: | 34.04 | Sell |
| 50-day SMA: | 32.86 | Sell |
| 200-day SMA: | 33.33 | Sell |
| 8-day EMA: | 33.17 | Sell |
| 20-day EMA: | 33.6 | Sell |
| 50-day EMA: | 33.05 | Sell |
| 200-day EMA: | 32.94 | Sell |
JANX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.16 | Buy |
| 20-day SMA: | 50.4 | Buy |
| 50-day SMA: | 49.88 | Buy |
| 200-day SMA: | 44.87 | Buy |
| 8-day EMA: | 49.16 | Buy |
| 20-day EMA: | 49.72 | Buy |
| 50-day EMA: | 49.41 | Buy |
| 200-day EMA: | 41.75 | Buy |
ProShares UltraShort 20+ Year Treasury Earnings Growth & TBT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Janux Therapeutics Earnings Growth & JANX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.91 per share.
ProShares UltraShort 20+ Year Treasury Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Janux Therapeutics Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||